Tislelizumab,Paclitaxel,Docetaxel,Irinotecan,nivolumab,ipilimumab,pembrolizumab
BeiGene,Novartis,BMS,Merck
['docetaxel', 'tislelizumab']
checkpoint inhibition in escc by markus m hler at #wcgic2023 
MD-PhD, MSc
Passionate Oncologist
Focus on Molecular Oncology 
Focus on Gastrointestinal Oncology